Postrenal Transplant Hemolytic Uremic Syndrome/Thrombotic Microangiopathy: Ahmedabad Experience

Transplantation Proceedings

Volumn 40, Issue 4, 2008, Pages 1114-1116

  Goplani, K R ^a   Vanikar, A V ^b   Shah, P R ^a   Gumber, M ^a   Feroz, A ^a   Patel, H V ^a   Kasat, P ^a   Falodia, J ^a   Saboo, D ^a   Kaswaan, K ^a   Geerish, M S ^a   Pandya, T ^a   Trivedi, H L ^a  

^a Research Centre   (India)

^b Transfusion Services and Immunohematology ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEMOLYTIC UREMIC SYNDROME; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; LABORATORY TEST; MALE; MEDICAL RECORD REVIEW; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; REGISTER; RETROSPECTIVE STUDY; SEROLOGY; THROMBOTIC THROMBOCYTOPENIC PURPURA;

GLOMERULAR MESANGIUM; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDIA; KIDNEY TRANSPLANTATION; PERIPHERAL VASCULAR DISEASES; RECURRENCE; RETROSPECTIVE STUDIES; THROMBOSIS;

EID: 44949197584     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.03.028     Document Type: Article

References (18)

1. Hochstetler L.A., Flanigan M.J., and Lager D.J. Transplant associated thrombotic microangiopathy: the role of IgG administration as initial therapy. Am J Kidney Dis 23 (1994) 444
2. Zarifian A., Meleg-Smith S., O'Donovan R., et al. Cyclosporine-associated thrombotic microangiopathy in renal allografts. Kidney Int 55 (1999) 2457
3. Racusen L.C., Colvin R.B., Solez K., et al. Anti-body mediated rejection criteria: an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 3 (2003) 708
4. Schwimmer J., Nadasdy T.A., Spitalnik P.F., et al. De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy. Am J Kidney Dis 41 (2003) 471
5. Ducloux D., Rebibou J.-M., Semhoun-Ducloux S., et al. Recurrence of hemolytic-uremic syndrome in renal transplant recipients: a meta-analysis. Transplantation 65 (1998) 1405
6. Artz M.A., Steenbergen E.J., Hoitsma A.J., et al. Renal transplantation in patients with haemolytic uremic syndrome: high rate of recurrence and increased incidence of rejections. Transplantation 76 (2003) 821
7. Remuzzi G., and Bertani T. Renal vascular and thrombotic effects of cyclosporine. Am J Kidney Dis 13 (1989) 261
8. Miller B.W., Hmiel S.P., Schnitzler M.A., et al. Cyclosporine as cause of thrombotic microangiopathy after renal transplantation. Am J Kidney Dis 29 (1997) 813
9. Curtis J.J. Renovascular elements of the cyclosporine injury. Transplant Proc 28 (1996) 2094
10. Grupp C., Schmidt F., Braun F., et al. Haemolytic uraemic syndrome (HUS) during treatment with cyclosporine A after renal transplantation-is tacrolimus the answer?. Nephrol Dial Transplant 13 (1998) 1629
11. Crew J.R., Radhakrishnan J., Cohen D.J., et al. De novo thrombotic microangiopathy following treatment with sirolimus: report of two cases. Nephrol Dial Transplant 20 (2005) 203
12. Reynolds J.C., Agodoa L.Y., Yuan C.M., et al. Thrombotic microangiopathy after renal transplantation in the United States. Am J Kidney Dis 42 (2003) 1058
13. Baid S., Pascual M., Williams Jr. W.W., et al. Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol 10 (1999) 146
14. Pham P.T., Peng A., Wilkinson A.H., et al. Cyclosporine and tacrolimus-associated thrombotic microangiopathy. Am J Kidney Dis 36 (2000) 844
15. Verpooten G.A., Paulus G.J., Roels F., et al. De novo occurrence of hemolytic-uremic syndrome in a cyclosporine-treated renal allograft patient. Transplant Proc 19 (1987) 2943
16. Wiener Y., Nakhleh R.E., Lee M.W., et al. Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome. Clin Transplant 11 (1997) 157
17. Zent R., Katz A., Quaggin S., et al. Thrombotic microangiopathy in renal transplant recipients treated with cyclosporine A. Clin Nephrol 47 (1997) 181
18. Bren A.F., Kandus A., Buturovic J., et al. Cyclosporine related hemolytic-uremic syndrome in kidney graft recipients: clinical and histomorphologic evaluation. Transplant Proc 30 (1998) 1201